Stefano Di Santo

Dr. Stefano Di Santo

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSStefano Di Santo
Stefano Di Santo
ZYZijiang Yang
Zijiang Yang
MBMoritz Wyler Von Ballmoos
Moritz Wyler Von Ballmoos
JVJan Voelzmann
Jan Voelzmann
NDNicolas Diehm
Nicolas Diehm
CKChristoph Kalka
Christoph Kalka
Current evidence suggests that endothelial progenitor cells (EPC) contribute to ischemic tissue repair by both secretion of paracrine factors and incorporation into developing vessels. We tested the hypothesis that cell-free administration of paracrine factors secreted by cultured EPC may achieve an angiogenic effect equivalent to cell therapy. EPC-derived conditioned medium (EPC-CM) was obtained from culture expanded EPC subjected to 72 hours of hypoxia. In vitro, EPC-CM significantly inhibited apoptosis of mature endothelial cells and promoted angiogenesis in a rat aortic ring assay. The therapeutic potential of EPC-CM as compared to EPC transplantation was evaluated in a rat model of chronic hindlimb ischemia. Serial intramuscular injections of EPC-CM and EPC both significantly increased hindlimb blood flow assessed by laser Doppler (81.2±2.9% and 83.7±3.0% vs. 53.5±2.4% of normal, P<0.01) and improved muscle performance. A significantly increased capillary density (1.62±0.03 and 1.68±0.05/muscle fiber, P<0.05), enhanced vascular maturation (8.6±0.3 and 8.1±0.4/HPF, P<0.05) and muscle viability corroborated the findings of improved hindlimb perfusion and muscle function. Furthermore, EPC-CM transplantation stimulated the mobilization of bone marrow (BM)-derived EPC compared to control (678.7±44.1 vs. 340.0±29.1 CD34+/CD45− cells/1×105 mononuclear cells, P<0.05) and their recruitment to the ischemic muscles (5.9±0.7 vs. 2.6±0.4 CD34+ cells/HPF, P<0.001) 3 days after the last injection. Intramuscular injection of EPC-CM is as effective as cell transplantation for promoting tissue revascularization and functional recovery. Owing to the technical and practical limitations of cell therapy, cell free conditioned media may represent a potent alternative for therapeutic angiogenesis in ischemic cardiovascular diseases.

1 July 2010 in Atherosclerosis
Verified
Journal Article
Closed access
ZYZijiang Yang
Zijiang Yang
MBMoritz Wyler von Ballmoos
Moritz Wyler von Ballmoos
DFDaniel Faessler
Daniel Faessler
JVJan Voelzmann
Jan Voelzmann
JOJana Ortmann
Jana Ortmann
CKChristoph Kalka
Christoph Kalka

1 January 2011 in Placenta
Verified
Journal Article
Closed access
SGS. Guller
S. Guller
ZTZ. Tang
Z. Tang
YMY.Y. Ma
Y.Y. Ma
SSStefano Di Santo
Stefano Di Santo
RSR. Sager
R. Sager
HSH. Schneider
H. Schneider

1 September 2003 in Placenta
Verified
Journal Article
Closed access
SSStefano Di Santo
Stefano Di Santo
AMA. Malek
A. Malek
RSR. Sager
R. Sager
AAA.-C. Andres
A.-C. Andres
HSH. Schneider
H. Schneider

1 January 2011 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
JOJana Ortmann
Jana Ortmann
MVMartha Veit
Martha Veit
SZSandra Zingg
Sandra Zingg
SSStefano Di Santo
Stefano Di Santo
TTTobias Traupe
Tobias Traupe
IBIris Baumgartner
Iris Baumgartner
Context: The decreased incidence of cardiovascular disease in premenopausal women has been attributed, at least partially, to protective effects of estrogens. However, premenopausal women with diabetes mellitus are no longer selectively protected. High-glucose (HG) conditions have previously been shown to abolish the antimitogenic effects of 17β-estradiol (E2) in vascular smooth muscle cells (VSMCs). Objective: Because E2 mediates its action via different estrogen receptor (ER) subtypes, we hypothesized that different subtypes may have different, if not opposing, effects on HG-induced VSMC proliferation. Methods and Results: Treatment of human aortic VSMCs isolated from premenopausal women with the selective ERα agonist, 4,4′,4′-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol, but not with E2, the selective ERβ agonist 2,3-bis(4-hydroxyphenyl)-propionitrile, or the selective G protein-coupled ER agonist G-1 completely prevented increased HG-induced VSMC proliferation. Under these conditions, ERα activation selectively prevented increased hydrogen peroxide (H2O2) and total intracellular reactive oxygen species (ROS) production, caused up-regulation of manganese superoxide dismutase protein and activity, and inhibited prolonged ERK phosphorylation. The latter was mediated by ROS, and ROS inhibition reversed HG-induced ERK-dependent VSMC proliferation. The selective coactivation of ERβ reversed the antimitogenic and antioxidative effects of ERα as well as the up-regulation of manganese superoxide dismutase protein expression. Conclusion: Selective activation of ERα is required for reducing oxidative stress and the consequent hyperproliferation of VSMCs under HG. Our results may further suggest that ERα activation inhibits HG-induced proliferation by down-regulating ROS-mediated ERK activation and may explain why antimitogenic effects of E2 are abolished under HG. Pharmacological activation of ERα may thus have therapeutic potential for treating cardiovascular dysregulation associated with diabetes.

1 November 2007 in Progress in Cardiovascular Diseases
Verified
Journal Article
Closed access
NDNicolas Diehm
Nicolas Diehm
FDFlorian Dick
Florian Dick
TSThomas Schaffner
Thomas Schaffner
JSJuerg Schmidli
Juerg Schmidli
CKChristoph Kalka
Christoph Kalka
IBIris Baumgartner
Iris Baumgartner